NANCY THOMAS: Open Payments
NPI 1922411941 · AUSTIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 17 payments from 8 companies in 2025. Trend: 2023 $48 · 2024 $262 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 5 | $122 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Alkermes, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $14 |
Products named: DOVATO, FANAPT, ARISTADA, Wegovy, CAPLYTA, TRELEGY ELLIPTA, INSPIRE, MAVYRET.
Industry payments across IN — which companies pay providers there.
